1887

Abstract

An oligonucleotide complementary to the splice donor sequence of the 1.8 kb gene family produced from the HI-H region of Marek's disease virus (MDV) DNA inhibited the proliferation of the MDV-derived lymphoblastoid cell line, MDCC-MSB1 (MSB-1), but not that of the avian lymphoid leukosis-derived lymphoblastoid cell line, LSCC-BK3. Colony formation in soft agar was also inhibited by treatment of MSB-1 cells with the antisense oligonucleotide. It is hypothesized that expression of the 1.8 kb gene family produced from the HI-H region is directly associated with the maintenance of the tumorigenic state of transformed Marek's disease-derived lymphoblastoid cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-5-1105
1991-05-01
2024-04-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/5/JV0720051105.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-5-1105&mimeType=html&fmt=ahah

References

  1. Agrawal S., Goodchild J., Civeira M. P., Thornton A. H., Sarin P. S., Zamecnik P. C. 1988; Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. Proceedings of the National Academy of Sciences, U,. S,. A 85:7079–7083
    [Google Scholar]
  2. Akiyama Y., Kato S. 1974; Two cell lines from lymphomas of Marek’s disease. Biken Journal 17:105–116
    [Google Scholar]
  3. Bradley G., Hayashi M., Lancz G., Tanaka A., Nonoyama M. 1989a; Structure of the Marek’s disease virus Bam HI-H gene family: genes of putative importance for tumor induction. Journal of Virology 63:2534–2542
    [Google Scholar]
  4. Bradley G., Lancz G., Tanaka A., Nonoyama M. 1989b; Loss of Marek’s disease virus tumorigenicity is associated with truncation of RNAs transcribed within Bam HI-H. Journal of Virology 63:4129–4135
    [Google Scholar]
  5. Churchill A. E., Chubb R. C., Baxendale W. 1969; The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek’s disease (strain HPRS-16) on passage in cell culture. Journal of General Virology 4:557–564
    [Google Scholar]
  6. Denhardt D. T. 1966; A membrane filter technique for the detection of complementary DNA. Biochemical and Biophysical Research Communications 23:641–646
    [Google Scholar]
  7. Fukuchi K., Sudo K., Lee Y., Tanaka A., Nonoyama M. 1985a; The structure of Marek’s disease virus DNA: detailed restriction enzyme map. Journal of Virology 51:102–109
    [Google Scholar]
  8. Fukuchi K., Tanaka A., Schierman L. W., Witter R. L., Nonoyama M. 1985b; The structure of Marek’s disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA. Proceedings of the National Academy of Sciences, U,. S,. A. 82:751–754
    [Google Scholar]
  9. Gewirtz A. M., Anfossi G., Venturelli D., Valpreda S., Sims R., Calabretta B. 1989; G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb . Science 245:180–183
    [Google Scholar]
  10. Hahn E. C., Ramos L., Kenyon A. J. 1977; Lymphoproliferative diseases of fowl: JM-V leukemic lymphoblasts in cell culture. Journal of the National Cancer Institute 59:267–269
    [Google Scholar]
  11. Hayashi M., Jessip J., Fukuchi K., Smith M., Tanaka A., Nonoyama M. 1988; The structure of Marek’s disease virus DNA: amplification of repeat sequence in IRS and TRS . Microbiology and Immunology 32:265–274
    [Google Scholar]
  12. Hihara H., Yamamoto H., Arai K., Okazaki W., Simizu T. 1980; Conditions for successful cultivation of tumor cells from chickens with avian lymphoid leukosis. Avian Diseases 24:971–979
    [Google Scholar]
  13. Lee L. E., Kieff E. D., Bachenheimer S. L., Roizman B., Spear P. G., Burmestar B. R., Nazerian K. 1971; Size and composition of Marek’s disease virus deoxyribonucleic acid. Journal of Virology 7:289–294
    [Google Scholar]
  14. Lemaitre M., Bayard B., Lebleu B. 1987; Specific antiviral activity of a poly(l-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proceedings of the National Academy of Sciences, U,. S,. A. 84:648–652
    [Google Scholar]
  15. Loke S. L., Stein C. A., Zhang X. H., Mori K., Nakanishi M., Subasinghe C., Cohen J. S., Neckers L. M. 1989; Characterization of oligonucleotide transport into living cells. Proceedings of the National Academy of Sciences, U,. S,. A 86:3474–3478
    [Google Scholar]
  16. McMaster G. K., Carmichael G. G. 1977; Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange. Proceedings of the National Academy of Sciences, U,. S,. A 74:4835–4838
    [Google Scholar]
  17. Maniatis T., Fritsch E. F., Sambrook J. 1982Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
  18. Maotani K., Kanamori A., Ikuta K., Ueda S., Kato S., Hirai K. 1986; Amplification of a tandem direct repeat within inverted repeats of Marek’s disease virus DNA during serial in vitro passage. Journal of Virology 58:657–659
    [Google Scholar]
  19. Marcus-Sekura C. J. 1988; Techniques for using antisense oligodeoxyribonucleotides to study gene expression. Analytical Biochemistry 172:289–295
    [Google Scholar]
  20. Mercola D., Westwick J., Rundell A. Y. K., Adamson E. D., Edwards S. A. 1988; Analysis of a transformed cell line using antisense c-fos RNA. Gene 72:253–265
    [Google Scholar]
  21. Miller P. S., Braiterman L. T., Ts’O P. O. P. 1977; Effects of a trinucleotide ethyl phosphotriester, Gmp(Et)Gmp(Et)U, on mammalian cells in culture. Biochemistry 16:1988–1996
    [Google Scholar]
  22. Nazerian K. 1970; Attenuation of Marek’s disease virus and study of its properties in two different cell cultures. Journal of the National Cancer Institute 44:1257–1267
    [Google Scholar]
  23. Rigby P. W. J., Dieckmann M., Rhodes C., Berg P. 1977; Labelling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. Journal of Molecular Biology 113:237–251
    [Google Scholar]
  24. Silva R. F., Witter R. L. 1985; Genomic expansion of Marek’s disease virus DNA is associated with serial in vitro passage. Journal of Virology 54:690–696
    [Google Scholar]
  25. Silver S., Smith M., Nonoyama M. 1979; Transcription of the Marek’s disease virus genome in virus-induced tumors. Journal of Virology 30:84–89
    [Google Scholar]
  26. Smith C. C., Aurelian L., Reddy M. P., Miller P. S., Ts’O P. O. P. 1986; Antiviral effect of an oligo(nucleoside methylphos-phonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5. Proceedings of the National Academy of Sciences, U,. S,. A. 83:2787–2791
    [Google Scholar]
  27. Southern E. M. 1975; Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 98:503–517
    [Google Scholar]
  28. Stein C. A., Cohen J. S. 1988; Oligodeoxynucleotides as inhibitors of gene expression: a review. Cancer Research 48:2659–2688
    [Google Scholar]
  29. Zamecnik P. C., Stephenson M. L. 1978; Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proceedings of the National Academy of Sciences, U,. S,. A 75:280–284
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-72-5-1105
Loading
/content/journal/jgv/10.1099/0022-1317-72-5-1105
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error